Skip to main content

News Archive

News Archive - All Stories

Live, Learn, Play: Vibrant New Neighborhood to Break Ground on Campus

June 7, 2018

When the North Torrey Pines Living and Learning Neighborhood breaks ground on June 18, a neighborhood like no other at UC San Diego will begin to take shape. Located between Muir and Marshall Colleges on the west campus, the new neighborhood will be a vibrant, mixed-use community incorporating residential, academic and administrative space, retail and parking.

A Global Community Affair

June 7, 2018

On June 8, the Conrad Prebys Music Center at UC San Diego will be home to “Interconnections for Peace: A Telematics Concert in San Diego, Seoul and NYC,” where top musicians in each of the three cities will be livestreamed together: just like playing in one global concert hall.

Speak Your Truth

June 7, 2018

For more than 20 years, Lucero Felicita Camarena felt a dissonance inside, assigned a gender that was incompatible with her internal sense of womanhood. In her experience as a Mexican-American raised by a single mother in Turlock, Calif., Camarena was never exposed to representations of transgender identity. By sharing her story as UC San Diego’s All Campus Commencement student speaker, she hopes to inspire courage in others to channel their truth as a powerful form of social change.

UC San Diego Ranked 3rd Among U.S. Public Universities in High-Quality Research

June 7, 2018

The University of California San Diego ranked 3rd among public research universities in the United States in this year’s annual ranking of high-quality scientific research papers by the journal Nature. In the Nature Index 2018 Annual Tables, the La Jolla campus ranked 12th in the world out of 500 institutions and 6th among U.S. universities in the research results its faculty, students and staff others published in 82 high-quality journals in 2017.

What’s Inside Your Medical Record?

June 6, 2018

Patients at UC San Diego Health can now read the medical notes signed by their primary care physician. This move toward transparency is part of an international trend to make patients feel more in control of their health care.

Antibody Blocks Inflammation, Protects Mice from Hardened Arteries and Liver Disease

June 6, 2018

Researchers at University of California San Diego School of Medicine discovered that they can block inflammation in mice with a naturally occurring antibody that binds oxidized phospholipids (OxPL), molecules on cell surfaces that get modified by inflammation. Even while on a high-fat diet, the antibody protected the mice from arterial plaque formation, hardening of the arteries and liver disease, and prolonged their lives.

UC San Diego Tops List of World’s ‘Golden Age’ Universities

June 6, 2018

For the second year in a row, the London-based Times Higher Education ranked UC San Diego the world’s number one research university founded during the “golden age” of higher education development, in the two decades between 1945 and 1967—when higher education was characterized by rapid university expansion and increasing investment in research.

UC San Diego Statement Regarding 2018 All Campus Commencement

June 5, 2018

Due to a UC-wide speaker boycott called by AFSCME Local 3299, Rep. John Lewis has withdrawn as UC San Diego’s commencement speaker. Leading the ceremony and speaking in his stead will be UC San Diego Chancellor Pradeep K. Khosla. Commencement is a very special milestone for our students, who have worked very hard to reach graduation and their achievement deserves to be recognized and celebrated appropriately. More details about UC San Diego commencement exercises can be found at commencement.ucsd.edu.

Phase I Trial Finds Experimental Drug Safe in Treating Chronic Lymphocytic Leukemia

June 1, 2018

Reporting results from a first-in-human phase I clinical trial, researchers at University of California San Diego School of Medicine have found that treatment with cirmtuzumab, an experimental monoclonal antibody-based drug, measurably inhibited the “stemness” of chronic lymphocytic leukemia cancer (CLL) cells — their ability to self-renew and resist terminal differentiation and senescence.

Stem Cell-Based Phase I Trial to Repair Spinal Cord Injuries Produces Encouraging Results

June 1, 2018

Researchers at University of California San Diego School of Medicine report that a first-in-human phase I clinical trial in which neural stem cells were transplanted into participants with chronic spinal cord injuries produced measurable improvement in three of four subjects, with no serious adverse effects.
Category navigation with Social links